EUVIMEDEUVIMED entdecken
Open Access

Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition

Cara Moloney, Tista Roy Chaudhuri, Joseph A Spernyak, Robert M Straubinger, Dermot F Brougham

Acta Biomaterialia · 2023-03 · 158 · 611-624

DOI: 10.1016/j.actbio.2022.12.057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-03. Verfasst von Cara Moloney und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Science Foundation Ireland, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanocarriers are candidates for cancer chemotherapy delivery, with growing numbers of clinically-approved nano-liposomal formulations such as Doxil® and Onivyde® (liposomal doxorubicin and irinotecan) providing proof-of-concept. However, their complex biodistribution and the varying susceptibility of individual patient tumours to nanoparticle deposition remains a clinical challenge. Here we describe the preparation, characterisation, and biological evaluation of phospholipidic structures containing solid magnetic cores (SMLs) as an MRI-trackable surrogate that could aid in the clinical development and deployment of nano-liposomal formulations. Through the sequential assembly of size-defined iron oxide nanoparticle clusters with a stabilizing anionic phospholipid inner monolayer and an outer monolayer of independently-selectable composition, SMLs can mimic physiologically a wide range of nano-liposomal carrier compositions. In patient-derived xenograft models of pancreatic adenocarcinoma, similar tumour deposition of SML and their nano-liposomal counterparts of identical bilayer composition was observed in vivo, both at the tissue level (fluorescence intensities of 1.5 × 108 ± 1.8 × 107 and 1.2 × 108 ± 6.3 × 107, respectively; ns, 99% confidence interval) and non-invasively using MR imaging. We observed superior capabilities of SML as a surrogate for nano-liposomal formulations as compared to other clinically-approved iron oxide nano-formulations (ferumoxytol). In combination with diagnostic and therapeutic imaging tools, SMLs have high clinical translational potential to predict nano-liposomal drug carrier deposition and could assist in stratifying patients into treatment regimens that promote optimal tumour deposition of nanoparticulate chemotherapy carriers. STATEMENT OF SIGNIFICANCE: Solid magnetoliposomes (SMLs) with compositions resembling that of FDA-approved agents such as Doxil® and Onivyde® offer potential application as non-invasive MRI stratification agents to assess extent of tumour deposition of nano-liposomal therapeutics prior to administration. In animals with pancreatic adenocarcinoma (PDAC), SML-PEG exhibited (i) tumour deposition comparable to liposomes of the same composition; (ii) extended circulation times, with continued tumour deposition up to 24 hours post-injection; and (iii) MRI capabilities to determine tumour deposition up to 1 week post-injection, and confirmation of patient-to-patient variation in nanoparticulate deposition in tumours. Hence SMLs with controlled formulation are a step towards non-invasive MRI stratification approaches for patients, enabled by evaluation of the extent of deposition in tumours prior to administration of nano-liposomal therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaPancreatic NeoplasmsNanoparticlesAnimalsHumansTissue DistributionDoxorubicinLiposomesPolyethylene Glycols

Stichwörter der Autor:innen

LiposomesMRI trackingMagnetic nanoparticlesPancreatic cancer

Substanzen

DoxorubicinLiposomesliposomal doxorubicinPolyethylene Glycols

Autor:innen und Institutionen

  • School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
  • Dept. of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA.
  • Department of Cell Stress Biology Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Dept. of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA; Department of Cell Stress Biology Roswell Park Comprehensive…
  • School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: dermot.brougham@ucd.ie.

Förderung

  • NCI NIH HHS
  • Science Foundation Ireland
  • NIH
  • Irish Research Council
  • Royal Society of Chemistry
  • European Association for Cancer Research

Zitieren

APA

Moloney, C., Roy Chaudhuri, T., Spernyak, J. A., Straubinger, R. M., & Brougham, D. F. (2023). Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition. Acta Biomaterialia, 158, 611-624. https://doi.org/10.1016/j.actbio.2022.12.057

Vancouver

Moloney C, Roy Chaudhuri T, Spernyak JA, Straubinger RM, Brougham DF. Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition. Acta Biomaterialia. 2023;158:611-624. doi:10.1016/j.actbio.2022.12.057

BibTeX
@article{Moloney2023,
  author = {Moloney, Cara and Roy Chaudhuri, Tista and Spernyak, Joseph A and Straubinger, Robert M and Brougham, Dermot F},
  title = {Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {158},
  pages = {611--624},
  doi = {10.1016/j.actbio.2022.12.057}
}
Kostenlos starten →